-
Abstract Number: VPB0943
Laboratory assessment of prothrombotic status in patients with primary brain tumors
-
Abstract Number: PB0412
Laboratory detection of Lupus Anticoagulant using Dilute Russell’s Viper Venom test (DRVVT) and/or Activated Partial Thromboplastin time (APTT): Does it matter?
-
Abstract Number: PB0180
Laboratory evaluation of extendend-half-life recombinant FVIII products (EHL-FVIIIs): one stage coagulation assay or chromogenic assay?
-
Abstract Number: VPB0227
Laboratory monitoring in haemophilia A patients with factor VIII inhibitor treated with emicizumab
-
Abstract Number: PB1085
Laboratory versus point-of-care INR testing in patients with lupus anticoagulant – a retrospective cohort analysis
-
Abstract Number: PB0812
Lack of Congruent VWF Levels, Genetics, and Bleeding Symptoms in Families with a Type 1 von Willebrand Disease Diagnosis
-
Abstract Number: PB0015
Left atrium size is associated with fibrin clot ultrastructure in patients with acute myocardial infarction
-
Abstract Number: OC 51.3
Leptin and IL-6 are linked to the mechanism underlying the prothrombotic state in obese pregnant women
-
Abstract Number: PO0015
Level of coagulation aberrations among COVID-19 patients in Ethiopia, Findings from the Horn of Africa
-
Abstract Number: VPB0468
Levels Of Heparin Induced Anti-PF4 Antibodies and Endogenous Glycosaminoglycans and Their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients.
-
Abstract Number: PB0559
LEX-210: a phase 3, randomized, double-blinded study of four-factor prothrombin complex concentrate in patients with acute major bleeding on direct oral anticoagulant therapy with factor Xa inhibitors
-
Abstract Number: VPB0492
LEX-211 (FARES-II): a phase 3, prospective, active-control randomised study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients
-
Abstract Number: PO0047
Life threatening thromboembolic event associated to pregnancy in an adolescent woman
-
Abstract Number: OC 35.1
Light-induced Ca2+ signaling triggers megakaryocyte polarization
-
Abstract Number: PB1302
Lineage specific vascular smooth muscle cell differentiation from pluripotent stem cells: A developmental bias towards aortic calcification
-
Abstract Number: OC 63.4
Little discrepancy of one-stage and chromogenic assays in a large international cohort of patients with non-severe hemophilia A and B (DYNAMO study)
-
Abstract Number: OC 37.5
Liver sinusoidal endothelial cells as a novel target for tolerance induction to FVIII
-
Abstract Number: OC 12.5
Liver Sinusoidal Endothelial Cells Targeted with Ultrasound Mediated Gene Delivery Shows Long Term FVIII Expression in Hemophilia A Mice
-
Abstract Number: VPB0514
LMWH safety and efficacy in pregnancy with rheumatic heart disease patients with heart valves replacement
-
Abstract Number: PB0679
Local experience of monitoring and effectiveness of Emicizumab in severe Haemophilia A
-
Abstract Number: VPB0110
Long-COVID-19 syndrome: from the clinical evidences to a pathophysiological mechanism
-
Abstract Number: OC 14.2
Long-term outcomes of superficial vein thrombosis in daily practice: 12-month data from the INSIGHTS-SVT study
-
Abstract Number: PB0098
Long-term persistence of anti-PF4-antibodies following Vaccine-Induced Thrombotic Thrombocytopenia after first ChAdOx1 vaccination.
-
Abstract Number: OC 43.2
Long-term reduction in blood transfusion incidence after correction of the shear-induced von Willebrand factor defect by TAVR-procedure
-
Abstract Number: VPB0470
Long-term results of tinzaparin for the treatment of superficial vein thrombosis of the lower limbs.
-
Abstract Number: OC 34.4
Long-Term Risk of Clinically Relevant Non-Major Bleeding During Extended Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-Analysis
-
Abstract Number: PB0310
Longitudinal kinetics of B-cell subsets in Immune Thrombotic Thrombocytopenic Purpura Patients: Relapses vs Remission
-
Abstract Number: PB0159
Loss of function variant in SMIM1 is associated with reduced energy expenditure, weight gain and an increased risk for cardiovascular events.
-
Abstract Number: PB1398
Loss of opportunities in the diagnosis and treatment of Primary obstetric antiphospholipid syndrome (POAPS). What is hidden behind the daily clinical practice?
-
Abstract Number: OC 53.5
Loss of Rab27A Targeting to Weibel-Palade Bodies in Endothelial Colony Forming Cells of Patients with Biallelic Mutations in the Guanine Nucleotide Exchange Factor MAP-Kinase Activating Death Domain
-
Abstract Number: PO0010
Loss of response after discontinuation of eltrombopag in a patient with immune thrombocytopenia secondary to COVID-19: another finding of “persistent COVID syndrome”?
-
Abstract Number: PB0405
Loss of zinc transporters ZIP1 and ZIP3 augments platelet reactivity in response to G protein-coupled receptor agonists and accelerates thrombus formation in vivo
-
Abstract Number: PB0304
Low ADAMTS13 activity rapid assay results in patients with low clinical probability of Thrombotic Thrombocytopaenic Purpura (TTP) – the United Kingdom experience
-
Abstract Number: PB0539
Low antithrombin levels are associated with low risk of cardiovascular death but are a risk factor for cancer mortality
-
Abstract Number: PB0926
Low concentrations of rFVIIa bypass changes in ROTEM coagulation parameters induced by abelacimab in vitro
-
Abstract Number: PB0779
Low expression of coagulation inhibitors in the immune microenvironment in precursor stages of multiple myeloma
-
Abstract Number: VPB0136
Low incidence of thromboembolism in hospitalized COVID-19 patients despite a very low thromboprophylaxis rate in Thailand
-
Abstract Number: PB0677
Low level mosaicism in a boy with mild haemophilia A excludes his mother as a carrier.
-
Abstract Number: PB0455
Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis. CAT-LONG study.
-
Abstract Number: PB0620
Low molecular weight heparin slows the formation of clots from patients within twenty-four hours of acute PE
-
Abstract Number: PB0189
Low normal levels of factor V enhance thrombin generation in hemophilia A
-
Abstract Number: PB0850
Lowe syndrome in platelets: OCRL controls the reorganization of actin and tubulin filaments during platelet activation
-
Abstract Number: VPB0516
Lp(a) increase calcium phosphate aortic valve mineralization in patients with a previous myocardial infarction.
-
Abstract Number: PB0041
Lung Ultrasound (LUS) for Thrombosis in COVID-19 Patients
-
Abstract Number: PB0078
Lupus anticoagulant as predictor for thrombosis in critically ill COVID-19 patients: a retrospective cohort study
-
Abstract Number: PB0064
Lupus anticoagulants as an independent predictor for disease severity in COVID-19 patients
-
Abstract Number: PB0154
Lyophilized human platelets are superior to apheresis or fresh-drawn platelets in their ability to accelerate thrombin production
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.